Key facts
- This page summarizes Vaddi Krishna's Form 4 filing for Prelude Therapeutics Inc (PRLD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Mar 2025, 16:37.
Vaddi Krishna - 25 Mar 2025 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)
- Reporting relationship
- CEO, Director
- Issuer ticker
- PRLD
- Reported as of
- 25 Mar 2025
- Net transaction value
- +$467,438
- SEC form
- 4
- Accepted by SEC
- 27 Mar 2025, 16:37:44 UTC
- Prior SEC filing
- 24 Mar 2025
- Next SEC filing
- 05 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bryant D. Lim, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Vaddi Krishna filed Form 4 for Prelude Therapeutics Inc (PRLD) on 27 Mar 2025.
Change
- Previous filing in this sequence was filed on 24 Mar 2025.
- Current net transaction value: +$467,438.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PRLD
transaction
Common Stock
Purchase
- Transaction value
- $467,438
- Shares
- +675,000
- Change %
- +51%
- Price
- $0.6925
- Shares after
- 1,999,296
- Date
- 25 Mar 2025
- Ownership
- Direct
PRLD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 423,655
- Date
- 25 Mar 2025
- Ownership
- By Trust
- Footnotes
- F1
PRLD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 551,774
- Date
- 25 Mar 2025
- Ownership
- By Trust
- Footnotes
- F2
PRLD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 551,776
- Date
- 25 Mar 2025
- Ownership
- By Trust
- Footnotes
- F3
PRLD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 142,553
- Date
- 25 Mar 2025
- Ownership
- See footnote
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The Reporting Person is a beneficiary of the Dolphin City Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
Footnote F2
The Reporting Person is the investment advisor of the Brocade Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
Footnote F3
The Reporting Person is the investment advisor of the Blue Sky Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
Footnote F4
The Reporting Person is the manager of Sidus Ventures LLC. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.